Literature DB >> 25969175

Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma.

Huaqiang Zhu1, Xu Zhou, Chaoqun Ma, Hong Chang, Hongguang Li, Fangfeng Liu, Jun Lu.   

Abstract

BACKGROUND/AIMS: miR-448 has been reported to exhibit abnormal expression in hepatocellular carcinoma (HCC), however, the essential role of miR-448 in HCC progression is still unclear.
METHODS: real-time PCR was used to detect the expression of miRNAs and candidate genes in HCC samples (n=117). miR-448 mimics and inhibitor were tansfected in human HCC cells. The transwell assay was used to examine the cell invasive ability. The regulation mechanism was confirmed by luciferase reporter assay. The markers of EMT were detected by using Western blot.
RESULTS: miR-448 was decreased in HCC samples and associated with HCC development. Inhibition of miR-448 significantly promoted cell invasion, while the effect of miR-448 up-regulation was reverse. miR-448 could regulate ROCK2 in hepatocellular carcinoma. Knockdown of ROCK2 expression partially reversed the effect of miR-448 inhibitor. Abnormal expression of miR-448 could regulate the markers of epithelial-mesenchymal transition (EMT).
CONCLUSIONS: miR-448 may contribute to the progression of HCC via regulating ROCK2 expression.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25969175     DOI: 10.1159/000430114

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  21 in total

1.  S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.

Authors:  Han Xu; Mengquan Li; Yue Zhou; Feng Wang; Xiangke Li; Liuxing Wang; Qingxia Fan
Journal:  Tumour Biol       Date:  2015-09-26

2.  miR-448 promotes progression of non-small-cell lung cancer via targeting SIRT1.

Authors:  Hongfeng Qi; Haifeng Wang; Dabin Pang
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

3.  miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.

Authors:  Xuesong Wu; Haoran Tang; Guobin Liu; Hui Wang; Jie Shu; Feng Sun
Journal:  Tumour Biol       Date:  2016-02-08

4.  MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.

Authors:  Ruihong Zhang; Li Sui; Xiaojian Hong; Mao Yang; Weimin Li
Journal:  Environ Sci Pollut Res Int       Date:  2017-08-11       Impact factor: 4.223

5.  MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.

Authors:  Yilang Wang; Xiaohong Chen; Ninghua Yao; Jun Gong; Yongfeng Cao; Xiaoqing Su; Xiu Feng; Min Tao
Journal:  J Gastrointest Oncol       Date:  2022-02

6.  NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Miyako Kurihara; Yukiko Nishiguchi; Rina Fujiwara; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2016-05-16       Impact factor: 4.064

7.  KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.

Authors:  Jun-Cheng Guo; Zhuo Liu; Yi-Jun Yang; Min Guo; Jian-Quan Zhang; Jin-Fang Zheng
Journal:  J Cell Mol Med       Date:  2021-04-07       Impact factor: 5.310

8.  Small nucleolar RNA SNORA71A promotes epithelial-mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer.

Authors:  Ting Hu; Chong Lu; Yun Xia; Lu Wu; Junlong Song; Chuang Chen; Qiong Wang
Journal:  Mol Oncol       Date:  2022-03-30       Impact factor: 7.449

9.  Phosphorylation of nucleophosmin at threonine 234/237 is associated with HCC metastasis.

Authors:  Rachel Hiu Ha Ching; Eunice Yuen Ting Lau; Patrick Ming Tat Ling; Joyce Man Fong Lee; Mark Kin Fai Ma; Bowie Yik Ling Cheng; Regina Cheuk Lam Lo; Irene Oi Lin Ng; Terence Kin Wah Lee
Journal:  Oncotarget       Date:  2015-12-22

10.  miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.

Authors:  Bai Li; Liang Ge; Minghe Li; Lei Wang; Zhihong Li
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.